Cargando…
Combination/augmentation strategies for improving the treatment of depression
Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the pres...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424118/ https://www.ncbi.nlm.nih.gov/pubmed/18568111 |
_version_ | 1782156246628958208 |
---|---|
author | Moret, Chantal |
author_facet | Moret, Chantal |
author_sort | Moret, Chantal |
collection | PubMed |
description | Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the present time, they are far from ideal and all show a similar slow, and frequently, incomplete response. Thus, the need for new and better compounds is as urgent and compelling as ever. While waiting for the panacea of future antidepressants, clinicians have developed a variety of associations of several antidepressants or an antidepressant with a second different agent. This article reviews the various strategies adopted by clinicians in the hope of increasing the response rate of current antidepressants to obtain full remission and/or to overcome treatment-resistant depression. |
format | Text |
id | pubmed-2424118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-24241182008-06-20 Combination/augmentation strategies for improving the treatment of depression Moret, Chantal Neuropsychiatr Dis Treat Review Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the present time, they are far from ideal and all show a similar slow, and frequently, incomplete response. Thus, the need for new and better compounds is as urgent and compelling as ever. While waiting for the panacea of future antidepressants, clinicians have developed a variety of associations of several antidepressants or an antidepressant with a second different agent. This article reviews the various strategies adopted by clinicians in the hope of increasing the response rate of current antidepressants to obtain full remission and/or to overcome treatment-resistant depression. Dove Medical Press 2005-12 /pmc/articles/PMC2424118/ /pubmed/18568111 Text en © 2005 Dove Medical Press Limited. All rights reserved |
spellingShingle | Review Moret, Chantal Combination/augmentation strategies for improving the treatment of depression |
title | Combination/augmentation strategies for improving the treatment of depression |
title_full | Combination/augmentation strategies for improving the treatment of depression |
title_fullStr | Combination/augmentation strategies for improving the treatment of depression |
title_full_unstemmed | Combination/augmentation strategies for improving the treatment of depression |
title_short | Combination/augmentation strategies for improving the treatment of depression |
title_sort | combination/augmentation strategies for improving the treatment of depression |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424118/ https://www.ncbi.nlm.nih.gov/pubmed/18568111 |
work_keys_str_mv | AT moretchantal combinationaugmentationstrategiesforimprovingthetreatmentofdepression |